Qazi-Markouizos syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3010OMIM:600096Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Qazi-Markouizos syndrome is an extremely rare genetic condition that affects multiple body systems, particularly the brain, face, and limbs. It is sometimes referred to as Qazi syndrome. The condition is present from birth and is characterized by a combination of features including an unusually large head (macrocephaly), distinctive facial features, intellectual disability, and abnormalities of the hands and feet. Some affected individuals may also have seizures and delayed development. The facial features associated with this syndrome can include a prominent forehead, widely spaced eyes, a broad or flat nasal bridge, and abnormalities of the ears. Hand and foot abnormalities may include extra fingers or toes (polydactyly), unusually broad thumbs or big toes, and other skeletal differences. Brain imaging may reveal structural abnormalities such as enlarged ventricles or other malformations. Because this syndrome is so rare, with only a handful of cases described in the medical literature, there is no specific cure or targeted treatment. Management focuses on addressing individual symptoms and may include therapies for developmental delays, seizure management with medications, and surgical correction of physical abnormalities when needed. A team of specialists is typically involved in the care of affected individuals.

Also known as:

Key symptoms:

Unusually large head (macrocephaly)Intellectual disabilityDelayed developmentSeizuresExtra fingers or toesBroad thumbs or big toesWidely spaced eyesProminent foreheadFlat or broad nasal bridgeAbnormal ear shapeBrain structural abnormalitiesLow muscle toneShort statureFeeding difficulties in infancy

Clinical phenotype terms (23)— hover any for plain English
Delayed ossification of carpal bonesHP:0001216Chronic constipationHP:0012450Dysharmonic skeletal maturationHP:0200000Broad philtrumHP:0000289Hypoplasia of teethHP:0000685Small nailHP:0001792
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Qazi-Markouizos syndrome.

View clinical trials →

No actively recruiting trials found for Qazi-Markouizos syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Qazi-Markouizos syndrome community →

No specialists are currently listed for Qazi-Markouizos syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Qazi-Markouizos syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Qazi-Markouizos syndromeForum →

No community posts yet. Be the first to share your experience with Qazi-Markouizos syndrome.

Start the conversation →

Latest news about Qazi-Markouizos syndrome

No recent news articles for Qazi-Markouizos syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific features of my child's condition led to this diagnosis?,Should we pursue genetic testing such as whole exome sequencing to look for a specific cause?,What therapies should we start right away to support my child's development?,How should we monitor for and manage seizures?,Are there any surgical options for the hand or foot abnormalities?,What is the expected developmental outlook for my child?,Are there any other family members who should be tested or evaluated?

Common questions about Qazi-Markouizos syndrome

What is Qazi-Markouizos syndrome?

Qazi-Markouizos syndrome is an extremely rare genetic condition that affects multiple body systems, particularly the brain, face, and limbs. It is sometimes referred to as Qazi syndrome. The condition is present from birth and is characterized by a combination of features including an unusually large head (macrocephaly), distinctive facial features, intellectual disability, and abnormalities of the hands and feet. Some affected individuals may also have seizures and delayed development. The facial features associated with this syndrome can include a prominent forehead, widely spaced eyes, a b

How is Qazi-Markouizos syndrome inherited?

Qazi-Markouizos syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Qazi-Markouizos syndrome typically begin?

Typical onset of Qazi-Markouizos syndrome is neonatal. Age of onset can vary across affected individuals.